Sweet expectations:Evidence and approach strategies of diagnosis and management of diabetes in pregnancy
Year: 2024
Type: other
Abstract: Chapter 9 -SUGAR-DIP trial: oral medication strategy versus insulin for diabetes in pregnancy, study protocol for a multicentre, open-label, non-inferiority, randomized controlled trial BMJ Open, 2019 Chapter 10 -Oral antihyperglycemic agent strategy versus insulin for gestational diabetes mellitus -a randomized controlled trial Submitted -Under embargo Chapter 11 -Summary Nederlandse samenvatting General discussion and future perspectives Portfolio CHAPTER 1 HistoryThe historical timeline of Diabetes Mellitus (DM) starts around 1500 BC; the initial documentation traces back to the ancient Egyptian Ebers Papyrus.Surprisingly, it was not until 1824 that Bennewitz in Germany described the first instance of diabetes occurring during pregnancy.The case involved a woman giving birth to a 5.5 kg baby, exhibiting intense thirst, recurrent glycosuria, and remarkably high glucose content (about 60 grams per 0.2 liters) in her urine.In 1882, Duncan delved into the outcomes of 16 women with 22 pregnancies affected by diabetes during gestation.High rates of maternal (60%) and neonatal (47%) mortality were observed.He noted that diabetes might solely manifest during pregnancy, being absent at other times, or resolving with pregnancy termination.In 1909, Williams' study in Baltimore added that urine containing glucose concentrations between 1 and 3 g/liter were likely associated with physiological conditions.However, higher glucose concentrations, especially when detected early in pregnancy or alongside symptoms, hinted at diabetes.This study potentially marked the inception of screening programs for diabetes in pregnancy.In the subsequent decades, from 1920 to 1930, several reports shed light on pancreatic abnormalities, particularly hypertrophy of Langerhans' islands, in stillborn infants of diabetic CHAPTER 1Subsequently, in 2013, the WHO issued new guidelines recommending the use of a three-point OGTT, which has since gained significant international adoption.In Part two in Chapter 4 we examine the relative contribution to GDM diagnoses, incidence and impact on cost-effectiveness of the three glucose values drawn during 3-point OGTT.Chapter 5 introduces the protocol of the TANGO-DM trial, a randomized controlled trial being conducted in the Netherlands, which aims to compare the WHO 1999 and WHO 2013 diagnostic criteria.Finally, Chapter 6 evaluates the impact of expanding diagnostic criteria, balancing the benefits and the potential harms and costs, through a series of systematic reviews and meta-analyses.
Author: Rademaker, D.
Language: English
Subfield: Obstetrics and Gynecology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7131930374
